175 related articles for article (PubMed ID: 28471803)
21. A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community Cohort.
Braun K; Sjoberg DD; Vickers AJ; Lilja H; Bjartell AS
Eur Urol; 2016 Mar; 69(3):505-11. PubMed ID: 25979570
[TBL] [Abstract][Full Text] [Related]
22. [An analysis of preliminary results in screening for prostatic cancer].
Matveev BP; Bukharkin BV; Komarova LE; Kadagidze ZG; Sholokhov VN; Sokolov AV; Smirnov AV; Cheban NL; Perederiĭ NV; Lepédatu PI
Urol Nefrol (Mosk); 1998; (2):30-4. PubMed ID: 9577701
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of the combined evaluation of KLK3 genetics and free-to-total prostate specific antigen ratio for prostate cancer diagnosis.
Zambon CF; Prayer-Galetti T; Basso D; Padoan A; Rossi E; Secco S; Pelloso M; Fogar P; Navaglia F; Moz S; Zattoni F; Plebani M
J Urol; 2012 Oct; 188(4):1124-30. PubMed ID: 22901566
[TBL] [Abstract][Full Text] [Related]
24. Predicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT study.
Bryant RJ; Sjoberg DD; Vickers AJ; Robinson MC; Kumar R; Marsden L; Davis M; Scardino PT; Donovan J; Neal DE; Lilja H; Hamdy FC
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25863334
[TBL] [Abstract][Full Text] [Related]
25. Risk assessment models to evaluate the necessity of prostate biopsies in North Chinese patients with 4-50 ng/mL PSA.
Zhao J; Liu S; Gao D; Ding S; Niu Z; Zhang H; Huang Z; Qiu J; Li Q; Li N; Xie F; Cui J; Lu J
Oncotarget; 2017 Feb; 8(6):9935-9946. PubMed ID: 28039477
[TBL] [Abstract][Full Text] [Related]
26. Prostate HistoScanning: a screening tool for prostate cancer?
De Coninck V; Braeckman J; Michielsen D
Int J Urol; 2013 Dec; 20(12):1184-90. PubMed ID: 23594146
[TBL] [Abstract][Full Text] [Related]
27. Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging.
Grönberg H; Eklund M; Picker W; Aly M; Jäderling F; Adolfsson J; Landquist M; Haug ES; Ström P; Carlsson S; Nordström T
Eur Urol; 2018 Dec; 74(6):722-728. PubMed ID: 30001824
[TBL] [Abstract][Full Text] [Related]
28. The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential.
Ström P; Nordström T; Aly M; Egevad L; Grönberg H; Eklund M
Eur Urol; 2018 Aug; 74(2):204-210. PubMed ID: 29331214
[TBL] [Abstract][Full Text] [Related]
29. A novel screening strategy for clinically significant prostate cancer in elderly men over 75 years of age.
Iwamoto H; Izumi K; Kadomoto S; Makino T; Naito R; Yaegashi H; Shigehara K; Kadono Y; Mizokami A
Asian J Androl; 2021; 23(1):36-40. PubMed ID: 32769233
[TBL] [Abstract][Full Text] [Related]
30. Utility of incorporating genetic variants for the early detection of prostate cancer.
Nam RK; Zhang WW; Trachtenberg J; Seth A; Klotz LH; Stanimirovic A; Punnen S; Venkateswaran V; Toi A; Loblaw DA; Sugar L; Siminovitch KA; Narod SA
Clin Cancer Res; 2009 Mar; 15(5):1787-93. PubMed ID: 19223501
[TBL] [Abstract][Full Text] [Related]
31. Personalized prostate cancer screening: improving PSA tests with genomic information.
Witte JS
Sci Transl Med; 2010 Dec; 2(62):62ps55. PubMed ID: 21160075
[TBL] [Abstract][Full Text] [Related]
32. Prebiopsy Biparametric Magnetic Resonance Imaging Combined with Prostate-specific Antigen Density in Detecting and Ruling out Gleason 7-10 Prostate Cancer in Biopsy-naïve Men.
Boesen L; Nørgaard N; Løgager V; Balslev I; Bisbjerg R; Thestrup KC; Jakobsen H; Thomsen HS
Eur Urol Oncol; 2019 May; 2(3):311-319. PubMed ID: 31200846
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide association study of serum prostate-specific antigen levels based on 1000 Genomes imputed data in Japanese: the Japan Multi-Institutional Collaborative Cohort Study.
Hishida A; Nakatochi M; Tamura T; Nagayoshi M; Okada R; Kubo Y; Tsukamoto M; Kadomatsu Y; Suzuki S; Nishiyama T; Kuriyama N; Watanabe I; Takezaki T; Nishimoto D; Kuriki K; Arisawa K; Katsuura-Kamano S; Mikami H; Kusakabe M; Oze I; Koyanagi YN; Nakamura Y; Kadota A; Shimanoe C; Tanaka K; Ikezaki H; Murata M; Kubo M; Momozawa Y; Takeuchi K; Wakai K;
Nagoya J Med Sci; 2021 Feb; 83(1):183-194. PubMed ID: 33727749
[TBL] [Abstract][Full Text] [Related]
34. A comprehensive resequence analysis of the KLK15-KLK3-KLK2 locus on chromosome 19q13.33.
Parikh H; Deng Z; Yeager M; Boland J; Matthews C; Jia J; Collins I; White A; Burdett L; Hutchinson A; Qi L; Bacior JA; Lonsberry V; Rodesch MJ; Jeddeloh JA; Albert TJ; Halvensleben HA; Harkins TT; Ahn J; Berndt SI; Chatterjee N; Hoover R; Thomas G; Hunter DJ; Hayes RB; Chanock SJ; Amundadottir L
Hum Genet; 2010 Jan; 127(1):91-9. PubMed ID: 19823874
[TBL] [Abstract][Full Text] [Related]
35. Initial biopsy outcome prediction in Korean patients-comparison of a noble web-based Korean prostate cancer risk calculator versus prostate-specific antigen testing.
Park JY; Yoon S; Park MS; Cho DY; Park HS; Moon du G; Yoon DK
J Korean Med Sci; 2011 Jan; 26(1):85-91. PubMed ID: 21218035
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide association study identifies novel single nucleotide polymorphisms having age-specific effect on prostate-specific antigen levels.
Li W; Bicak M; Sjoberg DD; Vertosick E; Dahlin A; Melander O; Ulmert D; Lilja H; Klein RJ
Prostate; 2020 Dec; 80(16):1405-1412. PubMed ID: 32914890
[TBL] [Abstract][Full Text] [Related]
37. A Pragmatic Approach to Prostate Cancer Screening.
Tosoian JJ; Penson DF; Chinnaiyan AM
JAMA; 2024 May; 331(17):1448-1450. PubMed ID: 38581253
[No Abstract] [Full Text] [Related]
38. Does genotyping of risk-associated single nucleotide polymorphisms improve patient selection for prostate biopsy when combined with a prostate cancer risk calculator?
Butoescu V; Ambroise J; Stainier A; Dekairelle AF; Gala JL; Tombal B
Prostate; 2014 Apr; 74(4):365-71. PubMed ID: 24265090
[TBL] [Abstract][Full Text] [Related]
39. Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore.
Verbeek JFM; Bangma CH; Kweldam CF; van der Kwast TH; Kümmerlin IP; van Leenders GJLH; Roobol MJ
Urol Oncol; 2019 Feb; 37(2):138-144. PubMed ID: 30528698
[TBL] [Abstract][Full Text] [Related]
40. Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels.
Cramer SD; Chang BL; Rao A; Hawkins GA; Zheng SL; Wade WN; Cooke RT; Thomas LN; Bleecker ER; Catalona WJ; Sterling DA; Meyers DA; Ohar J; Xu J
J Natl Cancer Inst; 2003 Jul; 95(14):1044-53. PubMed ID: 12865450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
